Changes in Beneficial Ownership · 4
InspireMD Inc.
NSPRNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-09-21
- Issuer
- InspireMD, Inc.
- Issuer CIK
- 0001433607
- Trading symbol
- NSPR
Reporting owner 1
- Name
- BERMAN MICHAEL
- Reporting owner CIK
- 0001186801
- Relationship
- Director
- Address
- C/O INSPIREMD, INC., 6303 WATERFORD DISTRICT DRIVE, SUITE 215, MIAMI, FL, 33126
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership | Nature of ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Series J Warrant (right to buy) | 1.3827 | 2026-09-18 | J · Form 4[F1] | 30,625 | D | 0 | 2023-05-15 | [F2] | Common Stock | 30,625 | 30,624 | I[F3] | See Footnote |
| Series J Warrant (right to buy) | 0.7674 | 2026-09-18 | J · Form 4[F1] | 30,625 | A | 0 | 2023-05-15 | [F4] | Common Stock | 30,625 | 30,625 | I[F3] | See Footnote |
| Series K Warrant (right to buy) | 1.3827 | 2026-09-18 | J · Form 4[F5] | 61,248 | D | 0 | 2023-05-15 | [F6] | Common Stock | 61,248 | 0 | I[F3] | See Footnote |
| Series K Warrant (right to buy) | 0.7674 | 2026-09-18 | J · Form 4[F5] | 61,248 | A | 0 | 2023-05-15 | [F7] | Common Stock | 61,248 | 61,248 | I[F3] | See Footnote |
Table key
- J · Form 4
- Other acquisition or disposition; see explanation
- D
- Disposed
- I
- Indirect
- A
- Acquired
Footnotes
Signature 1
- Signed
- /s/ Michael Lawless, Attorney-in-Fact for Michael Berman
- Date
- 2026-09-23
Filed exhibits
- EX-99.1 ↗ex99-1.htm
Company context
InspireMD seeks to utilize its proprietary MicroNet ™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on the Company’s website. For more information, please visit www.inspiremd.com.